201 related articles for article (PubMed ID: 21294785)
1. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
Chung LP; Waterer G; Thompson PJ
Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
[TBL] [Abstract][Full Text] [Related]
2. Clinical consequences of ADRbeta2 polymorphisms.
Hawkins GA; Weiss ST; Bleecker ER
Pharmacogenomics; 2008 Mar; 9(3):349-58. PubMed ID: 18303970
[TBL] [Abstract][Full Text] [Related]
3. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
4. Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics.
van Veen A; Wierenga EA; Westland R; Weller FR; Hart GA; Jansen HM; Jonkers RE
Respir Res; 2006 Jan; 7(1):19. PubMed ID: 16448568
[TBL] [Abstract][Full Text] [Related]
5. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
6. Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response.
Vonk JM; Postma DS; Maarsingh H; Bruinenberg M; Koppelman GH; Meurs H
Pharmacogenet Genomics; 2010 Mar; 20(3):179-86. PubMed ID: 20124949
[TBL] [Abstract][Full Text] [Related]
7. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of β2-agonists.
Hizawa N
Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
[TBL] [Abstract][Full Text] [Related]
9. Beta2 adrenergic receptor (ADRβ2) haplotype pair (2/4) is associated with severe asthma.
Chung LP; Baltic S; Ferreira M; Temple S; Waterer G; Thompson PJ
PLoS One; 2014; 9(4):e93695. PubMed ID: 24691493
[TBL] [Abstract][Full Text] [Related]
10. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
11. A safety review of long-acting beta2-agonists in patients with asthma.
Rider NL; Craig TJ
J Am Osteopath Assoc; 2006 Sep; 106(9):562-7. PubMed ID: 17079526
[TBL] [Abstract][Full Text] [Related]
12. Beta2-receptor polymorphisms in asthma.
Kelly HW
Lancet; 2009 Nov; 374(9703):1726-8. PubMed ID: 19932345
[No Abstract] [Full Text] [Related]
13. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
14. An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment.
Contopoulos-Ioannidis DG; Alexiou GA; Gouvias TC; Ioannidis JP
Pharmacogenet Genomics; 2006 Oct; 16(10):705-11. PubMed ID: 17001289
[TBL] [Abstract][Full Text] [Related]
15. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
[TBL] [Abstract][Full Text] [Related]
16. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
17. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
18. Beta-2 adrenergic receptor genetic polymorphisms and asthma.
Hizawa N
J Clin Pharm Ther; 2009 Dec; 34(6):631-43. PubMed ID: 20175796
[TBL] [Abstract][Full Text] [Related]
19. Beta2-adrenoceptor polymorphisms predict response to beta2-agonists in children with acute asthma.
Martin AC; Zhang G; Rueter K; Khoo SK; Bizzintino J; Hayden CM; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN
J Asthma; 2008 Jun; 45(5):383-8. PubMed ID: 18569231
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in response to asthma medications.
Tamesis GP; Krawiec ME
Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):185-9. PubMed ID: 17351474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]